Back to Search
Start Over
[The Hypertension Optimal Treatment (HOT) study: results of 12-month therapy related to age].
- Source :
-
Deutsche medizinische Wochenschrift (1946) [Dtsch Med Wochenschr] 1998 Jan 02; Vol. 123 (1-2), pp. 1-5. - Publication Year :
- 1998
-
Abstract
- Background and Objective: The prospective, randomized multicentre HOT study (Hypertension Optimal Treatment) is at present being undertaken in 26 countries. The cardinal questions to be answered were: (1) the relationship between three targeted diastolic pressures (< or = 90, < or = 85 and < or = 80 mm Hg, respectively) and cardiovascular morbidity and mortality rates among hypertensives; and (2) the effect of low dosage aspirin (75 mg daily) on morbidity and mortality rates, compared with a placebo.<br />Patients and Methods: A total of 19,193 patients (9056 women, 10,137 men; age range 50-80 years) with a diastolic blood pressure of > or = 100 to < or = 115 mm Hg were randomized. Antihypertensive treatment was begun with the calcium-channel blocker felodipine (5 mg once daily; step 1). When the target could not be reached at this dosage, an angiotensin-converting enzyme inhibitor (ACEI) or beta-receptor blocker was added (stage two), after which felodipine, 10 mg daily, could be given, if necessary (step 3). Any necessary changes in dosage (step 4) were made according to a prescribed plan. As fifth and final step a diuretic could be additionally administered. One-year results are now available for all patients and reported here. Results of older patients (> or = 65 years, n = 6113) were compared to those of younger patients (< 65 years, n = 13,080).<br />Results: Average diastolic pressure in the previously < or = 90 mm Hg group had been reduced to 86 mm Hg, in the < or = 85 group to 83 mm Hg, and in the < or 80 mm Hg group to 81 mm Hg. The percentage proportion of patients in whom the targeted pressures had been reached after 12 months of treatment were: 84% for the < 90 mm Hg group, 72% in the < 85 mm Hg group and 57% in the < 80 mm Hg group. In a subgroup of elderly patients (> 65 years, n = 6113) the corresponding percentage proportions were higher: 86%, 76% and 61%. Side effects were noted only rarely, despite the intensive treatment (> 65 years and < 65 years): ankle oedema in 2.6% and 3.0%; and cough in 1.3 and 0.8%, an overall incidence of > or = 1%. The same treatment (with felodipine) was still being given after one year to 88% of all patients.<br />Conclusion: These results after one year indicate that most patients well tolerate consistent blood pressure reduction. This raises the hope that the primary questions of the study can be answered.
- Subjects :
- Adrenergic beta-Antagonists therapeutic use
Age Factors
Aged
Aged, 80 and over
Angiotensin-Converting Enzyme Inhibitors therapeutic use
Aspirin administration & dosage
Aspirin therapeutic use
Calcium Channel Blockers administration & dosage
Calcium Channel Blockers therapeutic use
Diastole
Diuretics
Felodipine administration & dosage
Felodipine therapeutic use
Female
Follow-Up Studies
Humans
Hydrochlorothiazide therapeutic use
Male
Middle Aged
Placebos
Platelet Aggregation Inhibitors administration & dosage
Platelet Aggregation Inhibitors therapeutic use
Prospective Studies
Risk Factors
Sodium Chloride Symporter Inhibitors therapeutic use
Time Factors
Antihypertensive Agents therapeutic use
Hypertension drug therapy
Subjects
Details
- Language :
- German
- ISSN :
- 0012-0472
- Volume :
- 123
- Issue :
- 1-2
- Database :
- MEDLINE
- Journal :
- Deutsche medizinische Wochenschrift (1946)
- Publication Type :
- Academic Journal
- Accession number :
- 9465848
- Full Text :
- https://doi.org/10.1055/s-2007-1023890